315 related articles for article (PubMed ID: 35070033)
1. Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.
Ezzat R; Eltabbakh M; El Kassas M
World J Gastrointest Oncol; 2021 Dec; 13(12):1919-1938. PubMed ID: 35070033
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis.
Lehman EM; Wilson ML
Int J Cancer; 2009 Feb; 124(3):690-7. PubMed ID: 18973270
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview.
Rashed WM; Kandeil MAM; Mahmoud MO; Ezzat S
J Egypt Natl Canc Inst; 2020 Jan; 32(1):5. PubMed ID: 32372179
[TBL] [Abstract][Full Text] [Related]
4. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
5. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.
Alavian SM; Haghbin H
Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803
[TBL] [Abstract][Full Text] [Related]
6. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.
Omar A; Kaseb A; Elbaz T; El-Kassas M; El Fouly A; Hanno AF; El Dorry A; Hosni A; Helmy A; Saad AS; Alolayan A; Eysa BE; Hamada E; Azim H; Khattab H; Elghazaly H; Tawfik H; Ayoub H; Khaled H; Saadeldin I; Waked I; Barakat EMF; El Meteini M; Hamed Shaaban M; EzzElarab M; Fathy M; Shaker M; Sobhi M; Shaker MK; ElGharib M; Abdullah M; Mokhtar M; Elshazli M; Heikal OMK; Hetta O; ElWakil RM; Abdel Wahab S; Eid SS; Rostom Y;
J Hepatocell Carcinoma; 2023; 10():1547-1571. PubMed ID: 37744303
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus and other risk factors in hepatocellular carcinoma.
Schiefelbein E; Zekri AR; Newton DW; Soliman GA; Banerjee M; Hung ChW; Seifeldin IA; Lo AC; Soliman AS
Acta Virol; 2012; 56(3):235-40. PubMed ID: 23043603
[TBL] [Abstract][Full Text] [Related]
8. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
Hassan MM; Zaghloul AS; El-Serag HB; Soliman O; Patt YZ; Chappell CL; Beasley RP; Hwang LY
J Clin Gastroenterol; 2001 Aug; 33(2):123-6. PubMed ID: 11468438
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.
Ziada DH; El Sadany S; Soliman H; Abd-Elsalam S; Salama M; Hawash N; Selim A; Hamisa M; Elsabagh HM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):257-262. PubMed ID: 27378258
[TBL] [Abstract][Full Text] [Related]
10. Current situation of viral hepatitis in Egypt.
Elbahrawy A; Ibrahim MK; Eliwa A; Alboraie M; Madian A; Aly HH
Microbiol Immunol; 2021 Sep; 65(9):352-372. PubMed ID: 33990999
[TBL] [Abstract][Full Text] [Related]
11. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Waziry R; Gomaa A; Waked I; Dore GJ
Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.
Zidan A; Scheuerlein H; Schüle S; Settmacher U; Rauchfuss F
Hepat Mon; 2012 Oct; 12(10 HCC):e6894. PubMed ID: 23233864
[TBL] [Abstract][Full Text] [Related]
14. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
15. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hashad DI; Elyamany AS; Salem PE
Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
[TBL] [Abstract][Full Text] [Related]
17. Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt.
Esmat G; Elbaz T; Elsharkawy A; Abdullah M; El Kassas M
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):637-642. PubMed ID: 32302245
[TBL] [Abstract][Full Text] [Related]
18. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
El-Mesery M; El-Mowafy M; Elgaml A; Youssef LF; Abed SY
J Interferon Cytokine Res; 2017 Aug; 37(8):342-347. PubMed ID: 28609212
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
